Drug Type Prophylactic vaccine, Genetically engineered subunit vaccine |
Synonyms |
Target |
Action antagonists |
Mechanism CMV gB antagonists(CMV gB antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cytomegalovirus Infections | Phase 2 | - | - |





